A selective inhibitor of PDE4A
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

ML-030

Item No. 15169

Technical Information
Formal Name
3-(2,5-dimethoxyphenyl)-6-(3,4-dimethoxyphenyl)-7H-1,2,4-triazolo[3,4-b][1,3,4]thiadiazine
CAS Number
1013750-77-0
Synonyms
  • CID-11757146
Molecular Formula
C20H20N4O4S
Formula Weight
Purity
≥98%
Formulation
A crystalline solid
λmax
324 nm
SMILES
COC1=C(OC)C=CC(C(CS2)=NN3C2=NN=C3C4=C(OC)C=CC(OC)=C4)=C1
InChi Code
InChI=1S/C20H20N4O4S/c1-25-13-6-8-16(26-2)14(10-13)19-21-22-20-24(19)23-15(11-29-20)12-5-7-17(27-3)18(9-12)28-4/h5-10H,11H2,1-4H3
InChi Key
DZAUSKKPHXFGNN-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    ML-030 is a triazolothiadiazine that inhibits PDE4 in a cell-based cyclic nucleotide-gated cation channel biosensor assay with an EC50 value of 18.7 nM.1,2 Among the PDE4 isoforms, ML-030 displays selectivity for inhibiting PDE4A (IC50 = 6.7 nM) over PDE4B1, PDE4B2, PDE4C1, and PDE4D2 (IC50 = 48.2, 37.2, 452, and 49.2 nM, respectively).1,2

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Skoumbourdis, A.P., Huang, R., Southall, N., et alIdentification of a potent new chemotype for the selective inhibition of PDE4. Bioorg. Med. Chem. Lett. 18(4), 1297-1303 (2008).

    2. Skoumbourdis, A.P., LeClair, C.A., Stefan, E., et alExploration and optimization of substituted triazolothiadiazines and triazolopyridazines as PDE4 inhibitors. Bioorg. Med. Chem. Lett. 19(13), 3686-3692 (2009).